glp 1 drug price reduction India's GLP-1 Adoption Lags Despite Cheaper Prices | Nithin Kamath posted on the topic Medicare Reports Significant Drug Price

Can Zepbound cause vision problems

2004Reversible dilated cardiomyopathy associated with glucagonoma

Bidens proposal was expensive: It would have included coverage for all state- and federally funded Medicaid programs, costing taxpayers as much as $35 billion over next decade

launched a biosimilar of the popular anti-diabetic drug Liraglutide in India, marketing it as Lirafit after obtaining approval from the Drug Controller General of India (DCGI)

At the 3.0 mg daily dose, liraglutide produced average weight losses on the order of ~8% in pivotal trials (SCALE program), with additional benefits in glycemic measures and cardiometabolic risk markers

Nature Genet